ClearOne is trading 14.3% up now at $11.20 after holders representing 61.3% of voting stock approved issuing 12.5 million shares to Vivani Medical for the Cortigent merger.

  • Approval removed a major closing condition and reduced transaction uncertainty.
  • ClearOne had already closed at $9.80 on August 6, up 166.3%.
  • Reported volume reached 64.5 million shares, indicating exceptionally active trading.